首页> 外国专利> antibody, antigen binding fragment of an antibody, chimeric molecule, chimeric antigen receptor, polynucleotide, cell, methods for preparing chimeric antigen receptor, for making an antibody, and for determining the presence of cd127 + cells, pharmaceutical composition, medium combination therapy, diagnostic method, and use of an anti-cd127 antibody or antigen-binding fragment thereof

antibody, antigen binding fragment of an antibody, chimeric molecule, chimeric antigen receptor, polynucleotide, cell, methods for preparing chimeric antigen receptor, for making an antibody, and for determining the presence of cd127 + cells, pharmaceutical composition, medium combination therapy, diagnostic method, and use of an anti-cd127 antibody or antigen-binding fragment thereof

机译:抗体,抗体的抗原结合片段,嵌合分子,嵌合抗原受体,多核苷酸,细胞,制备嵌合抗原受体,制备抗体和确定cd127 +细胞的存在的方法,药物组合物,介质联合疗法,诊断cd127抗体或其抗原结合片段的方法和用途

摘要

The invention relates to humanized antibodies directed against the extracellular domain of the interleukin 7 (il-7) receptor alpha chain, especially against the human il-7 receptor expressed in human cells (also called human 7ralfa or il-7ra). or cd127) and does not interfere with the il-7 or tslp signaling pathways. The antibodies of the invention have no il-7 receptor antagonistic effect, but may still exhibit cytotoxic activity against cd127 positive cells. In a particular embodiment, the antibody has no agonistic effect on the il-7 receptor.
机译:本发明涉及针对白介素7(IL-7)受体α链的细胞外结构域的人源化抗体,特别是针对在人细胞(也称为人7ralfa或IL-7RA)中表达的人IL-7受体。或cd127),并且不会干扰il-7或tslp信号通路。本发明的抗体没有il-7受体拮抗作用,但仍可能表现出对cd127阳性细胞的细胞毒活性。在一个具体的实施方案中,该抗体对il-7受体没有激动作用。

著录项

  • 公开/公告号BR112018067479A2

    专利类型

  • 公开/公告日2019-01-15

    原文格式PDF

  • 申请/专利权人 OSE IMMUNOTHERAPEUTICS;

    申请/专利号BR20181167479

  • 发明设计人 CAROLINE MARY;NICOLAS POIRIER;

    申请日2017-02-28

  • 分类号C07K16/28;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号